Condition
    Strong Evidence
    Effectiveness 9/5

    Vitamin B12 for B12 Deficiency

    For confirmed B12 deficiency, supplementation is not optional — it is the treatment. Oral high-dose therapy corrects most cases; injections are reserved for pernicious anemia or severe neurological symptoms.

    Overview

    Correcting a genuine B12 deficiency is one of the highest-value interventions in supplementation, because untreated deficiency can cause irreversible nerve damage while treatment is cheap, well tolerated and largely predictable. Haematological features, the macrocytic anaemia, correct almost completely. Neurological features correct in proportion to how long they were present. The main practical revision of the last two decades is the route. High-dose oral B12, 1000 to 2000 mcg daily, achieves haematological and neurological responses comparable to intramuscular injection in most people, because a passive diffusion pathway absorbs about 1 percent of a large oral dose independently of intrinsic factor. Injections still matter where absorption is genuinely gone or the presentation is severe: symptomatic neurological deficits, post-gastrectomy or ileal resection, or a person who will not take a daily tablet reliably.

    Verdict

    Strong yes

    Repletion reliably corrects the anaemia and biochemical markers, and high-dose oral therapy matches injection for most causes. Neurological recovery depends on how early treatment starts, so delay is the main risk.

    How It Works

    B12 is a cofactor for two reactions. Methionine synthase converts homocysteine to methionine, supplying methyl groups for DNA and myelin maintenance. Methylmalonyl-CoA mutase converts methylmalonyl-CoA to succinyl-CoA. Blocking the first raises homocysteine and stalls DNA synthesis, producing the megaloblastic anaemia. Blocking the second raises methylmalonic acid and disrupts myelin, producing the neuropathy and subacute combined degeneration of the cord. Absorption normally requires stomach acid, then intrinsic factor from parietal cells, then a specific ileal receptor. Pernicious anaemia destroys intrinsic factor production, acid-suppressing drugs and metformin impair earlier steps, and ileal disease or resection removes the receptor. Running alongside all of that is a small, non-saturable passive diffusion route that absorbs roughly 1 percent of any oral dose. That is precisely why 1000 mcg tablets work in pernicious anaemia.

    Pathways involved

    Methionine synthase and the methylation cycle
    Methylmalonyl-CoA mutase and myelin maintenance
    Intrinsic factor and ileal cubam receptor uptake
    Passive diffusion of roughly 1 percent of large oral doses
    Methylmalonic acid as a sensitive functional marker
    Folate trap and masked deficiency

    Dosing & Protocol

    1. 1

      Confirm it before treating it· Week 0

      Serum B12 plus, where the result is borderline (roughly 150-300 pmol/L), methylmalonic acid or homocysteine. Check folate and ferritin at the same time.

    2. 2

      Find the cause· Week 0-1

      Vegan or low-animal-food diet, metformin, long-term proton pump inhibitors, coeliac or Crohn disease, gastric or ileal surgery, or intrinsic factor antibodies. The cause decides the route and duration.

    3. 3

      Start repletion· Weeks 1-12

      1000 mcg oral daily for most people. Injections if neurological signs are present, absorption is surgically absent, or adherence is unreliable.

    4. 4

      Recheck and settle· Week 12 and annually

      Expect reticulocytosis within a week and full blood count normalisation by 8 weeks. Neurological improvement can take 6 to 12 months and may be incomplete.

    Do not treat folate first and B12 later

    Folate alone can correct the anaemia while the neurological damage continues, because it restores DNA synthesis without restoring myelin maintenance. Where both are low, B12 goes first or both start together. This is the one sequencing error in B12 care that causes lasting harm.

    Evidence

    A Cochrane review of oral versus intramuscular B12 found comparable normalisation of serum B12 and haematological markers, with oral therapy at 1000 to 2000 mcg daily performing as well as injections for most causes of deficiency. That review reframed route as a matter of preference, absorption severity and adherence rather than efficacy. The foundational work here is older. A 1998 trial in Blood demonstrated effective treatment of cobalamin deficiency with 2000 mcg oral cobalamin, including in patients with pernicious anaemia, which is the observation the passive diffusion route explains. A large cohort from the Diabetes Prevention Program Outcomes Study established long-term metformin use as a genuine cause of low B12, making it a routine thing to check rather than a curiosity. What supplementation does not do is improve cognition in people who are not deficient: a randomised trial in older adults found no neurologic or cognitive benefit from supplementation without deficiency.

    Studies linked to this pairing, newest first.

    Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial

    Score: 9/10
    2015
    rct
    n=201

    Dangour AD, Allen E, Clarke R +7 more

    Vitamin B-12 supplementation for 12 months in older people with moderate vitamin B-12 deficiency had no effect on peripheral nerve conduction, central motor conduction or cognitive function.

    View source

    Vitamin B12 and Neurological Function

    Score: 8/10
    2006

    Reynolds E

    Vitamin B12 deficiency causes a spectrum of neurological disturbances, and early recognition and repletion are essential to prevent irreversible damage.

    View source

    Effective treatment of cobalamin deficiency with oral cobalamin

    Score: 8/10
    1998
    rct
    n=38

    Kuzminski AM, Del Giacco EJ, Allen RH +2 more

    Daily oral administration of 2000 microg of cyanocobalamin was as effective as, and possibly superior to, 1000 microg administered intramuscularly in correcting cobalamin deficiency.

    View source

    Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency

    Score: 9/10
    2018
    systematic_review
    n=153

    Wang H, Li L, Qin LL +3 more

    High oral doses of vitamin B12 (1000 mcg and 2000 mcg) were as effective as intramuscular administration in obtaining short term haematological and neurological responses in vitamin B12 deficient patients.

    View source

    Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

    Score: 8/10
    2016
    cohort

    Aroda VR, Edelstein SL, Goldberg RB +8 more

    Long-term use of metformin was associated with biochemical B12 deficiency and anemia, supporting the need for routine measurement of B12 levels during long-term metformin treatment.

    View source
    Passive absorption of a large oral dose
    About 1 percent, independent of intrinsic factor
    Oral dose matching injection
    1000-2000 mcg daily in most causes
    Reticulocyte response
    Within about 1 week of adequate repletion
    Blood count normalisation
    Usually by 8 weeks
    Neurological recovery window
    6-12 months, and incomplete if treatment was late
    Benefit without deficiency
    No demonstrated cognitive or neurologic gain

    Safety

    B12 is water soluble, has no established upper intake level, and excess is excreted in urine. Doses of 1000 to 2000 mcg daily are standard clinical practice, and toxicity is not the concern. The real hazards sit around treatment rather than in it. Severe deficiency being repleted quickly can drop serum potassium as new red cells consume it, which matters most where deficiency was profound or the person is already on diuretics. Rare acneiform or rosacea-like eruptions can follow high-dose therapy. Hydroxocobalamin injections occasionally cause hypersensitivity reactions. The more common harm is diagnostic. Starting supplements before testing makes serum B12 uninterpretable for months, so anyone with unexplained neuropathy, anaemia or cognitive change should be tested first.

    Neurological symptoms are a same-week medical issue

    Numbness or tingling in the feet or hands, unsteadiness in the dark, memory change or a burning tongue alongside a low B12 needs clinical assessment now, not a supplement trial. Subacute combined degeneration of the spinal cord becomes permanent the longer it goes untreated, and delay is the only part of this condition that is truly irreversible.

    Interactions & Conflicts

    Most B12 conflicts are about absorption upstream of the vitamin, which is why they cause the deficiency rather than interfering with treatment. High-dose oral therapy largely bypasses them. Metformin and long-term acid suppression are the two most common causes seen in practice, and both are usually worth continuing while the B12 is replaced. Nitrous oxide is the sharp exception: it inactivates methylcobalamin directly and can precipitate an acute neurological presentation in someone already marginal. Folate is the interaction to get the order right on, since correcting it alone can mask progressing neurological damage.
    Interacts withSeverityMechanismAction
    Metformin
    moderate
    		Reduced ileal B12 absorption with long-term useCheck B12 every 1-2 years; replace orally and continue metformin
    Proton pump inhibitors and H2 blockers
    moderate
    		Less acid means less B12 released from food proteinUse supplemental B12, which does not need acid to be freed; review ongoing need for acid suppression
    Nitrous oxide
    high
    		Direct oxidative inactivation of methylcobalaminAvoid recreational use entirely if B12 is low; tell anaesthetists about known deficiency before surgery
    Folic acid
    moderate
    		Corrects the anaemia while neurological damage continuesTreat B12 first or start both together; never folate alone when both are low
    Colchicine, neomycin, prolonged antibiotic use
    low
    		Impaired ileal absorptionMonitor B12 with prolonged use
    Potassium-losing diuretics during rapid repletion
    moderate
    		New red cell production consumes potassiumHave potassium checked when treating severe deficiency

    References

    1. Wang H et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018
    2. Kuzminski AM et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998
    3. Aroda VR et al. Long-term metformin use and vitamin B12 deficiency in the DPP Outcomes Study. J Clin Endocrinol Metab. 2016
    4. Devalia V et al. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014
    5. NIH Office of Dietary Supplements — Vitamin B12 Fact Sheet for Health Professionals

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.